Pharmacies that sold the lipo-busting drug Serostim may face federal investigation, according to court documents filed in yesterday’s $704 million settlement. According to the Boston Globe, the allegation is that some pharmacies may have accepted 4% discounts on Serostim in violation of federal drug pricing rules.